Table of Contents
Executive Summary
1 Industry Overview of Ocular Drug Delivery
1.1 Definition of Ocular Drug Delivery
1.2 Ocular Drug Delivery Segment By Technology
1.2.1 Global Ocular Drug Delivery Production Growth Rate Comparison By Technology (2014-2025)
1.2.2 Ocular Insert
1.2.3 Iontophoresis
1.2.4 Intraocular Implants
1.2.5 In Situ Gel & Punctal Plugs
1.2.6 Others
1.3 Ocular Drug Delivery Segment by Applications
1.3.1 Global Ocular Drug Delivery Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Ophthalmic Clinics
1.3.5 Homecare Settings
1.4 Global Ocular Drug Delivery Overall Market
1.4.1 Global Ocular Drug Delivery Revenue (2014-2025)
1.4.2 Global Ocular Drug Delivery Production (2014-2025)
1.4.3 North America Ocular Drug Delivery Status and Prospect (2014-2025)
1.4.4 Europe Ocular Drug Delivery Status and Prospect (2014-2025)
1.4.5 China Ocular Drug Delivery Status and Prospect (2014-2025)
1.4.6 Japan Ocular Drug Delivery Status and Prospect (2014-2025)
1.4.7 Southeast Asia Ocular Drug Delivery Status and Prospect (2014-2025)
1.4.8 India Ocular Drug Delivery Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Ocular Drug Delivery
2.3 Manufacturing Process Analysis of Ocular Drug Delivery
2.4 Industry Chain Structure of Ocular Drug Delivery
3 Development and Manufacturing Plants Analysis of Ocular Drug Delivery
3.1 Capacity and Commercial Production Date
3.2 Global Ocular Drug Delivery Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Ocular Drug Delivery
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Ocular Drug Delivery Production and Capacity Analysis
4.2 Ocular Drug Delivery Revenue Analysis
4.3 Ocular Drug Delivery Price Analysis
4.4 Market Concentration Degree
5 Ocular Drug Delivery Regional Market Analysis
5.1 Ocular Drug Delivery Production by Regions
5.1.1 Global Ocular Drug Delivery Production by Regions
5.1.2 Global Ocular Drug Delivery Revenue by Regions
5.2 Ocular Drug Delivery Consumption by Regions
5.3 North America Ocular Drug Delivery Market Analysis
5.3.1 North America Ocular Drug Delivery Production
5.3.2 North America Ocular Drug Delivery Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Ocular Drug Delivery Import and Export
5.4 Europe Ocular Drug Delivery Market Analysis
5.4.1 Europe Ocular Drug Delivery Production
5.4.2 Europe Ocular Drug Delivery Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Ocular Drug Delivery Import and Export
5.5 China Ocular Drug Delivery Market Analysis
5.5.1 China Ocular Drug Delivery Production
5.5.2 China Ocular Drug Delivery Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Ocular Drug Delivery Import and Export
5.6 Japan Ocular Drug Delivery Market Analysis
5.6.1 Japan Ocular Drug Delivery Production
5.6.2 Japan Ocular Drug Delivery Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Ocular Drug Delivery Import and Export
5.7 Southeast Asia Ocular Drug Delivery Market Analysis
5.7.1 Southeast Asia Ocular Drug Delivery Production
5.7.2 Southeast Asia Ocular Drug Delivery Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Ocular Drug Delivery Import and Export
5.8 India Ocular Drug Delivery Market Analysis
5.8.1 India Ocular Drug Delivery Production
5.8.2 India Ocular Drug Delivery Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Ocular Drug Delivery Import and Export
6 Ocular Drug Delivery Segment Market Analysis (by Type)
6.1 Global Ocular Drug Delivery Production by Type
6.2 Global Ocular Drug Delivery Revenue by Type
6.3 Ocular Drug Delivery Price by Type
7 Ocular Drug Delivery Segment Market Analysis (by Application)
7.1 Global Ocular Drug Delivery Consumption by Application
7.2 Global Ocular Drug Delivery Consumption Market Share by Application (2014-2019)
8 Ocular Drug Delivery Major Manufacturers Analysis
8.1 OCULAR THERAPEUTIX, INC
8.1.1 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Production Sites and Area Served
8.1.2 OCULAR THERAPEUTIX, INC Product Introduction, Application and Specification
8.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Alimera Sciences
8.2.1 Alimera Sciences Ocular Drug Delivery Production Sites and Area Served
8.2.2 Alimera Sciences Product Introduction, Application and Specification
8.2.3 Alimera Sciences Ocular Drug Delivery Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Allergan, Plc
8.3.1 Allergan, Plc Ocular Drug Delivery Production Sites and Area Served
8.3.2 Allergan, Plc Product Introduction, Application and Specification
8.3.3 Allergan, Plc Ocular Drug Delivery Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 EyeGate Pharma
8.4.1 EyeGate Pharma Ocular Drug Delivery Production Sites and Area Served
8.4.2 EyeGate Pharma Product Introduction, Application and Specification
8.4.3 EyeGate Pharma Ocular Drug Delivery Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Valeant Pharmaceuticals International, Inc
8.5.1 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Production Sites and Area Served
8.5.2 Valeant Pharmaceuticals International, Inc Product Introduction, Application and Specification
8.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Envisia Therapeutics
8.6.1 Envisia Therapeutics Ocular Drug Delivery Production Sites and Area Served
8.6.2 Envisia Therapeutics Product Introduction, Application and Specification
8.6.3 Envisia Therapeutics Ocular Drug Delivery Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Clearside Biomedical
8.7.1 Clearside Biomedical Ocular Drug Delivery Production Sites and Area Served
8.7.2 Clearside Biomedical Product Introduction, Application and Specification
8.7.3 Clearside Biomedical Ocular Drug Delivery Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Graybug Vision Inc
8.8.1 Graybug Vision Inc Ocular Drug Delivery Production Sites and Area Served
8.8.2 Graybug Vision Inc Product Introduction, Application and Specification
8.8.3 Graybug Vision Inc Ocular Drug Delivery Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Taiwan Liposome Company
8.9.1 Taiwan Liposome Company Ocular Drug Delivery Production Sites and Area Served
8.9.2 Taiwan Liposome Company Product Introduction, Application and Specification
8.9.3 Taiwan Liposome Company Ocular Drug Delivery Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Santen Pharmaceutical Co., Ltd
8.10.1 Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Production Sites and Area Served
8.10.2 Santen Pharmaceutical Co., Ltd Product Introduction, Application and Specification
8.10.3 Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Ocular Drug Delivery Market
9.1 Global Ocular Drug Delivery Market Trend Analysis
9.1.1 Global Ocular Drug Delivery Market Size (Volume and Value) Forecast 2019-2025
9.2 Ocular Drug Delivery Regional Market Trend
9.2.1 North America Ocular Drug Delivery Forecast 2019-2025
9.2.2 Europe Ocular Drug Delivery Forecast 2019-2025
9.2.3 China Ocular Drug Delivery Forecast 2019-2025
9.2.4 Japan Ocular Drug Delivery Forecast 2019-2025
9.2.5 Southeast Asia Ocular Drug Delivery Forecast 2019-2025
9.2.6 India Ocular Drug Delivery Forecast 2019-2025
9.3 Ocular Drug Delivery Market Trend (Product Type)
9.4 Ocular Drug Delivery Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Ocular Drug Delivery Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Ocular Drug Delivery
Table Global Ocular Drug Delivery Production (K Doses) Growth Rate Comparison by Types (2014-2025)
Figure Global Ocular Drug Delivery Production Market Share by Types in 2018
Figure Ocular Insert Product Picture
Figure Iontophoresis Product Picture
Figure Intraocular Implants Product Picture
Figure In Situ Gel & Punctal Plugs Product Picture
Figure Others Product Picture
Table Global Ocular Drug Delivery Consumption (K Doses) Comparison by Applications (2014-2025)
Figure Global Ocular Drug Delivery Consumption Market Share by Applications in 2018
Figure Hospitals
Figure Ambulatory Surgical Centers
Figure Ophthalmic Clinics
Figure Homecare Settings
Figure Global Ocular Drug Delivery Revenue (Million USD) (2014-2025)
Figure Global Ocular Drug Delivery Production (K Doses) (2014-2025)
Figure North America Ocular Drug Delivery Market Size (Million USD) (2014-2025)
Figure Europe Ocular Drug Delivery Market Size (Million USD) (2014-2025)
Figure China Ocular Drug Delivery Market Size (Million USD) (2014-2025)
Figure Japan Ocular Drug Delivery Market Size (Million USD) (2014-2025)
Figure Southeast Asia Ocular Drug Delivery Market Size (Million USD) (2014-2025)
Figure India Ocular Drug Delivery Market Size (Million USD) (2014-2025)
Table Ocular Drug Delivery Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Ocular Drug Delivery in 2018
Figure Manufacturing Process Analysis of Ocular Drug Delivery
Figure Industry Chain Structure of Ocular Drug Delivery
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Ocular Drug Delivery Manufacturing Plants Distribution
Table Ocular Drug Delivery Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Ocular Drug Delivery Capacity (K Doses) of Major Manufacturers (2014-2019)
Table Ocular Drug Delivery Production (K Doses) of Major Manufacturers (2014-2019)
Table Ocular Drug Delivery Production Market Share of Major Manufacturers (2014-2019)
Figure Ocular Drug Delivery Production Share by Manufacturers in 2018
Table Ocular Drug Delivery Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Ocular Drug Delivery Revenue Market Share of Major Manufacturers (2014-2019)
Figure Ocular Drug Delivery Revenue Share by Manufacturers in 2018
Table Ocular Drug Delivery Average Price (USD/Dose) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Ocular Drug Delivery Production by Regions 2014-2019 (K Doses)
Table Global Ocular Drug Delivery Production Market Share by Regions 2014-2019
Figure Global Ocular Drug Delivery Production Market Share by Regions in 2018
Table Global Ocular Drug Delivery Revenue by Regions 2014-2019 (Million USD)
Table Global Ocular Drug Delivery Revenue Market Share by Regions 2014-2019
Figure Global Ocular Drug Delivery Revenue Market Share by Regions in 2018
Table Global Ocular Drug Delivery Consumption by Regions 2014-2019 (K Doses)
Table Global Ocular Drug Delivery Consumption Market Share by Regions 2014-2019
Figure North America Ocular Drug Delivery Production Growth Rate 2014-2019 (K Doses)
Figure North America Ocular Drug Delivery Revenue Growth Rate 2014-2019 (Million USD)
Table North America Ocular Drug Delivery Production, Consumption Import and Export (K Doses)
Figure Europe Ocular Drug Delivery Production Growth Rate 2014-2019 (K Doses)
Figure Europe Ocular Drug Delivery Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Ocular Drug Delivery Production, Consumption Import and Export (K Doses)
Figure China Ocular Drug Delivery Production Growth Rate 2014-2019 (K Doses)
Figure China Ocular Drug Delivery Revenue Growth Rate 2014-2019 (Million USD)
Table China Ocular Drug Delivery Production, Consumption Import and Export (K Doses)
Figure Japan Ocular Drug Delivery Production Growth Rate 2014-2019 (K Doses)
Figure Japan Ocular Drug Delivery Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Ocular Drug Delivery Production, Consumption Import and Export (K Doses)
Figure Southeast Asia Ocular Drug Delivery Production Growth Rate 2014-2019 (K Doses)
Figure Southeast Asia Ocular Drug Delivery Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Ocular Drug Delivery Production, Consumption Import and Export (K Doses)
Figure India Ocular Drug Delivery Production Growth Rate 2014-2019 (K Doses)
Figure India Ocular Drug Delivery Revenue Growth Rate 2014-2019 (Million USD)
Table India Ocular Drug Delivery Production, Consumption Import and Export (K Doses)
Figure Global Consumption Ocular Drug Delivery Market Share by Application (2014-2019)
Figure Global Value (Consumption) Ocular Drug Delivery Market Share by Application (2014-2019)
Table OCULAR THERAPEUTIX, INC Ocular Drug Delivery Production Sites and Area Served
Table OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product Introduction, Application and Specification
Table OCULAR THERAPEUTIX, INC Ocular Drug Delivery Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table OCULAR THERAPEUTIX, INC Ocular Drug Delivery Production Growth Rate (2014-2019)
Table OCULAR THERAPEUTIX, INC Ocular Drug Delivery Production Market Share (2014-2019)
Figure OCULAR THERAPEUTIX, INC Ocular Drug Delivery Revenue Market Share (2014-2019)
Table OCULAR THERAPEUTIX, INC Ocular Drug Delivery Main Business and Markets Served
Table Alimera Sciences Ocular Drug Delivery Production Sites and Area Served
Table Alimera Sciences Ocular Drug Delivery Product Introduction, Application and Specification
Table Alimera Sciences Ocular Drug Delivery Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Alimera Sciences Ocular Drug Delivery Production Growth Rate (2014-2019)
Table Alimera Sciences Ocular Drug Delivery Production Market Share (2014-2019)
Figure Alimera Sciences Ocular Drug Delivery Revenue Market Share (2014-2019)
Table Alimera Sciences Ocular Drug Delivery Main Business and Markets Served
Table Allergan, Plc Ocular Drug Delivery Production Sites and Area Served
Table Allergan, Plc Ocular Drug Delivery Product Introduction, Application and Specification
Table Allergan, Plc Ocular Drug Delivery Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Allergan, Plc Ocular Drug Delivery Production Growth Rate (2014-2019)
Table Allergan, Plc Ocular Drug Delivery Production Market Share (2014-2019)
Figure Allergan, Plc Ocular Drug Delivery Revenue Market Share (2014-2019)
Table Allergan, Plc Ocular Drug Delivery Main Business and Markets Served
Table EyeGate Pharma Ocular Drug Delivery Production Sites and Area Served
Table EyeGate Pharma Ocular Drug Delivery Product Introduction, Application and Specification
Table EyeGate Pharma Ocular Drug Delivery Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table EyeGate Pharma Ocular Drug Delivery Production Growth Rate (2014-2019)
Table EyeGate Pharma Ocular Drug Delivery Production Market Share (2014-2019)
Figure EyeGate Pharma Ocular Drug Delivery Revenue Market Share (2014-2019)
Table EyeGate Pharma Ocular Drug Delivery Main Business and Markets Served
Table Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Production Sites and Area Served
Table Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Product Introduction, Application and Specification
Table Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Production Growth Rate (2014-2019)
Table Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Production Market Share (2014-2019)
Figure Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Revenue Market Share (2014-2019)
Table Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Main Business and Markets Served
Table Envisia Therapeutics Ocular Drug Delivery Production Sites and Area Served
Table Envisia Therapeutics Ocular Drug Delivery Product Introduction, Application and Specification
Table Envisia Therapeutics Ocular Drug Delivery Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Envisia Therapeutics Ocular Drug Delivery Production Growth Rate (2014-2019)
Table Envisia Therapeutics Ocular Drug Delivery Production Market Share (2014-2019)
Figure Envisia Therapeutics Ocular Drug Delivery Revenue Market Share (2014-2019)
Table Envisia Therapeutics Ocular Drug Delivery Main Business and Markets Served
Table Clearside Biomedical Ocular Drug Delivery Production Sites and Area Served
Table Clearside Biomedical Ocular Drug Delivery Product Introduction, Application and Specification
Table Clearside Biomedical Ocular Drug Delivery Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Clearside Biomedical Ocular Drug Delivery Production Growth Rate (2014-2019)
Table Clearside Biomedical Ocular Drug Delivery Production Market Share (2014-2019)
Figure Clearside Biomedical Ocular Drug Delivery Revenue Market Share (2014-2019)
Table Clearside Biomedical Ocular Drug Delivery Main Business and Markets Served
Table Graybug Vision Inc Ocular Drug Delivery Production Sites and Area Served
Table Graybug Vision Inc Ocular Drug Delivery Product Introduction, Application and Specification
Table Graybug Vision Inc Ocular Drug Delivery Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Graybug Vision Inc Ocular Drug Delivery Production Growth Rate (2014-2019)
Table Graybug Vision Inc Ocular Drug Delivery Production Market Share (2014-2019)
Figure Graybug Vision Inc Ocular Drug Delivery Revenue Market Share (2014-2019)
Table Graybug Vision Inc Ocular Drug Delivery Main Business and Markets Served
Table Taiwan Liposome Company Ocular Drug Delivery Production Sites and Area Served
Table Taiwan Liposome Company Ocular Drug Delivery Product Introduction, Application and Specification
Table Taiwan Liposome Company Ocular Drug Delivery Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Taiwan Liposome Company Ocular Drug Delivery Production Growth Rate (2014-2019)
Table Taiwan Liposome Company Ocular Drug Delivery Production Market Share (2014-2019)
Figure Taiwan Liposome Company Ocular Drug Delivery Revenue Market Share (2014-2019)
Table Taiwan Liposome Company Ocular Drug Delivery Main Business and Markets Served
Table Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Production Sites and Area Served
Table Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Product Introduction, Application and Specification
Table Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Production Growth Rate (2014-2019)
Table Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Production Market Share (2014-2019)
Figure Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Revenue Market Share (2014-2019)
Table Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Main Business and Markets Served
Figure Global Ocular Drug Delivery Production (K Doses) Growth Rate Forecast 2019-2025
Figure Global Ocular Drug Delivery Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Ocular Drug Delivery Sales Price (USD/Dose) Forecast 2019-2025
Figure North America Ocular Drug Delivery Production Growth Rate Forecast 2019-2025 (K Doses)
Figure North America Ocular Drug Delivery Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Ocular Drug Delivery Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Europe Ocular Drug Delivery Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Ocular Drug Delivery Production Growth Rate Forecast 2019-2025 (K Doses)
Figure China Ocular Drug Delivery Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Ocular Drug Delivery Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Japan Ocular Drug Delivery Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Ocular Drug Delivery Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Southeast Asia Ocular Drug Delivery Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Ocular Drug Delivery Production Growth Rate Forecast 2019-2025 (K Doses)
Figure India Ocular Drug Delivery Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Doses) of Ocular Drug Delivery by Type (2019-2025)
Table Global Consumption (K Doses) of Ocular Drug Delivery by Application (2019-2025)
Table Ocular Drug Delivery Distributors List
Table Ocular Drug Delivery Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
【掲載企業】
OCULAR THERAPEUTIX, INC、Alimera Sciences、Allergan, Plc、EyeGate Pharma、Valeant Pharmaceuticals International, Inc、Envisia Therapeutics、Clearside Biomedical、Graybug Vision Inc、Taiwan Liposome Company、Santen Pharmaceutical Co., Ltd、